EUTM file information

018764651

HederaDx


September 20, 2022

Trademark Summary

The trademark HederaDx was filed by Hedera Dx SA, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on October 20, 2022, and received one opposition filed on January 22, 2023 by Hedera Hashgraph, LLC on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by COOLEY and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 22, 2023

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

Change of name and professional address of the trademark registration was recorded on November 23, 2023.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Medical preparations
    3. Medical diagnostic reagents and assays for testing of body fluids
    4. Reagents for use in diagnostic tests [for medical purposes]
    5. Diagnostic biomarker reagents for medical purposes
    6. Medical diagnostic reagents
    7. Kits, containing medical substances or diagnostic agents for medical use
    8. Diagnostic testing kits comprised of medical diagnostic reagents and assays for testing body fluids
    9. Reagents for use in medical genetic testing.
  • The mark was filed in class 9 with following description of goods:
    1. Computer software
    2. Recorded and downloadable media
    3. Software for use in the medical field
    4. Software for analysing blood samples and blood-based cancer tests
    5. Computer software relating to the medical field
    6. Artificial intelligence and machine learning software
    7. Computer software for use in medical decision support systems
    8. Artificial intelligence software for analytics
    9. Web-based software application to manage the ordering, analysis and reporting of cancer diagnostic tests
    10. Software for bioinformatics research and analysis
    11. Mobile computing and operating platforms consisting of data transceivers, wireless networks and gateways for collection and management of data
    12. Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services
    2. Scientific research services
    3. Technological research services
    4. Research, development, design and upgrading of computer software
    5. Computer-assisted scientific research
    6. Diagnostic testing and analysis services
    7. Design, maintenance, development and updating of computer software
    8. Blood analysis services for scientific research purposes
    9. Hosting of online platforms
    10. Development of computer platforms
    11. Providing online, non-downloadable software
    12. Provision of software on platforms that allow users to access and use software
    13. Software as a service (SaaS)
    14. Software as a service [SaaS] featuring computer software platforms for artificial intelligence
    15. Platform as a service [PaaS]
    16. Hosting platforms on the Internet
    17. Provision of scientific information through web-based platforms
    18. Cloud computing services
    19. Providing temporary use of on-line non-downloadable software and applications for use in diagnosing or screening for cancer
    20. Providing temporary use of on-line non-downloadable cloud computing software for use in diagnosing or screening cancer.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services
    2. Advisory services relating to medical services
    3. Genetic testing and reporting for medical purposes
    4. Medical diagnostic services
    5. Medical testing for diagnostic or treatment purposes
    6. Medical and health services relating to DNA, genetics and genetic testing
    7. Medical screening
    8. Medical diagnostic testing, monitoring and reporting services
    9. Genetic analysis and reporting services for medical purposes
    10. Providing information in the field of cancer prevention, screening, diagnosis and treatment
    11. Cancer screening services
    12. Medical analysis services relating to the treatment of patients
    13. Medical analysis services for cancer diagnosis and prognosis
    14. Medical laboratory services for the analysis of samples taken from patients
    15. Providing medical information to patients and medical professionals in the form of reports in the field of cancer
    16. Services for the preparation of medical reports.